Dasanix 50 Mg (Dasatinib) – 60 Tablets
$ 135.00
Dasanix 50 Mg (Dasatinib) is a potent targeted therapy designed to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Containing Dasatinib, Dasanix 50 mg works by inhibiting the activity of BCR-ABL kinase, an abnormal protein produced by the Philadelphia chromosome, which drives the growth of cancerous cells. This medication is particularly effective in managing CML and Ph+ ALL, offering patients a powerful treatment option to control the progression of these cancers.
Dasanix is indicated for the treatment of:
- Chronic Myeloid Leukemia (CML): Dasanix is used in both chronic and advanced phases of CML, helping to achieve and maintain remission by targeting the BCR-ABL fusion protein.
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Dasanix 50 mg is also indicated for the treatment of Ph+ ALL, particularly in patients who are newly diagnosed or have shown resistance or intolerance to previous treatments.
⭐️⭐️⭐️⭐️⭐️
Product Feature:
Manufacturer | : Beacon Pharmaceuticals Ltd. |
Indication | : Chronic myeloid leukaemia. |
Generic | : Dasatinib |
Formulation | : Tablet |
Pack Size | : 60 Tablets |
Strengths | : 50 Mg |
Storage | : Below 30°C |
You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Dasanix 50 Mg (Dasatinib) medicine.
Reviews
There are no reviews yet.